Radiation Therapy
‘Harmful effect’ of pandemic emerges as clinics see patients with more advanced cancer
New patients arrived at cancer clinics with more advanced disease than prior to the COVID-19 pandemic as treatment postponements and deferrals subsided, according to results of a physician survey by American Society for Radiation Oncology.
City of Hope appoints radiation oncology chair
Terence M. Williams, MD, PhD, has been appointed chair of City of Hope’s department of radiation oncology.
VIDEO: Non-transplant approach may benefit some Hodgkin lymphoma patients
Radiation-based approaches may offer an alternative to stem cell transplant for some patients with relapsed or refractory classical Hodgkin lymphoma, according to an analysis presented at ASH Annual Meeting and Exposition.
Older women with early breast cancer may be able to avoid radiation after surgery
The omission of radiation therapy after breast-conserving surgery did not affect survival among certain older women with early breast cancer, according to results presented at the virtual San Antonio Breast Cancer Symposium.
Symptoms often underrecognized among patients receiving radiotherapy for breast cancer
Symptoms such as pain, fatigue and pruritus often went underrecognized among patients with breast cancer treated with radiotherapy, according to study results presented at the virtual San Antonio Breast Cancer Symposium.
Radiation therapy safe before CAR T-cell infusion for advanced multiple myeloma
Localized radiation therapy appeared safe before treatment with chimeric antigen receptor T cells for relapsed or refractory multiple myeloma, according to study results presented at the virtual ASTRO Annual Meeting.
Number of U.S. radiotherapy facilities rises, but many Americans still lack close access
Although the percentage of U.S. radiation facilities has increased in the past 15 years, urban areas already dense with these facilities have been disproportionately favored, according to a presenter at the virtual ASTRO Annual Meeting.
Racial minority groups underrepresented in radiation therapy clinical trials
The racial diversity of radiation therapy clinical trials did not appear to match that of the 2018 U.S. Census population, according to study results presented at the virtual ASTRO Annual Meeting.
FDA grants orphan drug designation to novel glioblastoma treatment
The FDA granted orphan drug designation to rhenium nanoliposomes for the treatment of patients with recurrent glioblastoma, according to a manufacturer-issued press release.
Radiotherapy for certain childhood cancers linked to long-term cardiometabolic effects
Adults who received radiation therapy during childhood for abdominal and pelvic cancers appeared more likely than the general population to experience body composition abnormalities and worse cardiometabolic outcomes, study results showed.